| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |